# Reviva Pharmaceuticals Holdings, Inc.: Form 8-K, filed May 30, 2025

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: 8-K
- Filed: 2025-05-30
- Accepted by EDGAR: May 30, 2025, 16:09 ET
- Period: 2025-05-30
- Accession: 0001437749-25-018972
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000143774925018972/rvph20250513_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000143774925018972/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000143774925018972/rvph20250513_8k.htm

Filed May 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-018972. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.